TrialClinical cancer research : an official journal of the American Association for Cancer Research2021

Phase I Trial of DNA Methyltransferase Inhibitor Guadecitabine Combined with Cisplatin and Gemcitabine for Solid Malignancies Including Urothelial Carcinoma (SPIRE).

Simon J Crabb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.